Pictet Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,214
Closed -$272K 2040
2025
Q2
$272K Sell
5,214
-179
-3% -$9.82K ﹤0.01% 1680
2025
Q1
$326K Buy
5,393
+1,275
+31% +$82.2K ﹤0.01% 1582
2024
Q4
$282K Hold
4,118
﹤0.01% 1674
2024
Q3
$296K Buy
4,118
+699
+20% +$49.3K ﹤0.01% 1620
2024
Q2
$237K Buy
3,419
+26
+0.8% +$1.9K ﹤0.01% 1672
2024
Q1
$272K Hold
3,393
﹤0.01% 1596
2023
Q4
$372K Hold
3,393
﹤0.01% 1418
2023
Q3
$342K Buy
+3,393
New +$390K ﹤0.01% 1404

Other funds holding CNMD

Pictet Asset Management's CNMD Position: Q3 2025 in Review

Pictet Asset Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 5,214 shares — an estimated $272K sold.

Pictet Asset Management first reported a position in CNMD in Q3 2023 and held it in 8 quarters. The position peaked at $372K in Q4 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Pictet Asset Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Pictet Asset Management sold 5,214 CONMED shares in Q3 2025, an estimated $272K.
  • Pictet Asset Management first reported a position in CONMED in Q3 2023 and held it in 8 quarters.
  • Pictet Asset Management's CONMED position peaked at $372K in Q4 2023.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Pictet Asset Management's 13F filing for Q3 2025, filed 18 Nov 2025.